Subchapter A - PRESCRIPTION AND SUBSTITUTION REQUIREMENTS

Section 562.001 - Definitions
Section 562.002 - Legislative Intent
Section 562.003 - Disclosure of Price; Patient's Option
Section 562.004 - Prescription Transmitted Orally By Practitioner
Section 562.005 - Record of Dispensed Drug or Biological Product
Section 562.0051 - Communication Regarding Certain Dispensed Biological Products
Section 562.006 - Label
Section 562.0061 - Other Prescription Information
Section 562.0062 - Required Statement Regarding Medication Disposal
Section 562.007 - Refills
Section 562.008 - Generic Equivalent or Interchangeable Biological Product Authorized
Section 562.009 - Requirements Concerning Selection of Generically Equivalent Drug or Interchangeable Biological Product
Section 562.010 - Responsibility Concerning Generically Equivalent Drug or Interchangeable Biological Product; Liability
Section 562.011 - Restriction on Selection of and Charging for Generically Equivalent Drug or Interchangeable Biological Product
Section 562.012 - Substitution of Dosage Form Permitted
Section 562.013 - Applicability of Subchapter
Section 562.014 - Narrow Therapeutic Index Drugs
Section 562.0141 - Transplant Immunosuppressant Drug Product Selection Prohibited
Section 562.0142 - Adoption of Rules
Section 562.015 - Dispensing Directive; Compliance With Federal Law
Section 562.016 - List of Approved Interchangeable Biological Products